Jg. Chai et al., SEED EXTRACT OF AEGINETIA-INDICA L INDUCES CYTOKINE PRODUCTION AND LYMPHOCYTE-PROLIFERATION IN-VITRO, Immunopharmacology, 27(1), 1994, pp. 13-21
We previously reported that the extract of seeds from Aeginetia Indica
L (AIL), a parasitic plant, induces potent antitumor immunity in tumo
r-bearing mice and that CD4(+) T cells appear to be the main contribut
ors in the induction of antitumor resistance. The present study was se
t up to investigate the in vitro effects of AIL on various lymphoid ce
lls. Spleen cells from mice pretreated with AIL every 2 days for 1 wee
k produced interleukin 2 (IL-2), interferon gamma (IFN gamma), tumor n
ecrosis factor (TNF) and interleukin 6 (IL-6) when these cells were st
imulated in vitro by AIL. Further, we found that CD4(+) T cells were m
ain producers of lL-2 and TNF upon the stimulation with ALL in vitro,
while both CD4(+) and CD8(+) T cells secreted IFN. On the other hand,
ALL was mitogenic in vitro to T enriched splenic lymphocytes as well a
s B enriched splenic lymphocytes. Moreover, AIL also proliferated thym
ocytes and this activity was potently synergistic with a suboptimal do
se of concanavalin A (Con A). Lipopolysaccharide (LPS) contamination i
n AIL preparation was negligible since proliferative activity of AIL t
o B enriched splenic lymphocytes was not influenced in the presence of
an endotoxin antagonist, polymyxin B sulfate (PMB). Further, B cell m
itogenic activity of AIL seems to be mediated by different mechanism(s
) from that of LPS since ALL could proliferate B enriched lymphocytes
of C3H/HeJ mice which do not respond to the stimulation with LPS. A we
ll known biological response modifier (BRM), Krestin (PSK), had no abi
lity in inducing either T or B lymphocyte activation in vitro as shown
by AIL. Taken together, the in vitro activities of AIL on the inducti
on of cytokine production and lymphocyte proliferation might contribut
e to the in vivo antitumor effect of AIL.